Annual Interest Expense
$1.10 M
+$1.09 M+17060.94%
31 December 2022
Summary:
Navidea Biopharmaceuticals annual interest expense is currently $1.10 million, with the most recent change of +$1.09 million (+17060.94%) on 31 December 2022. During the last 3 years, it has risen by +$1.09 million (+17060.94%). NAVB annual interest expense is now -37.05% below its all-time high of $1.74 million, reached on 31 December 2008.NAVB Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
N/A
30 September 2023
Summary:
Navidea Biopharmaceuticals quarterly interest expense is not available.NAVB Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
N/A
30 September 2023
Summary:
Navidea Biopharmaceuticals TTM interest expense is not available.NAVB TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAVB Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | +10000.0% | - | - |
5 y5 years | - | - | - |
NAVB Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | >+9999.0% | ||||
5 y | 5 years | at high | >+9999.0% | ||||
alltime | all time | -37.0% | >+9999.0% |
Navidea Biopharmaceuticals Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | $263.20 K(+7013.5%) | $263.20 K(+7013.5%) |
Dec 2022 | $1.10 M(>+9900.0%) | - | - |
Mar 2022 | - | $3700.00(+27.6%) | $3700.00(+27.6%) |
Dec 2021 | $6400.00(+30.6%) | - | - |
Mar 2021 | - | $2900.00(+20.8%) | $2900.00(+20.8%) |
Mar 2020 | - | $2400.00(-99.8%) | $2400.00(-99.9%) |
Dec 2016 | $4900.00(-99.6%) | - | - |
Dec 2015 | $1.27 M(+8.9%) | - | - |
Sept 2013 | - | $976.20 K(+109.8%) | $2.04 M(+47.9%) |
June 2013 | - | $465.30 K(+28.1%) | $1.38 M(+11.6%) |
Mar 2013 | - | $363.10 K(+53.9%) | $1.24 M(+5.9%) |
Dec 2012 | $1.17 M | $236.00 K(-25.2%) | $1.17 M(+24.0%) |
Sept 2012 | - | $315.30 K(-1.9%) | $940.50 K(+50.3%) |
June 2012 | - | $321.40 K(+9.4%) | $625.80 K(+104.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | $293.70 K(+2807.9%) | $305.50 K(+2179.9%) |
Dec 2011 | $13.30 K(-97.6%) | $10.10 K(+1583.3%) | $13.40 K(+197.8%) |
Sept 2011 | - | $600.00(-45.5%) | $4500.00(-4.3%) |
June 2011 | - | $1100.00(-31.3%) | $4700.00(-98.3%) |
Mar 2011 | - | $1600.00(+33.3%) | $272.20 K(-51.0%) |
Dec 2010 | $555.00 K(-63.8%) | $1200.00(+50.0%) | $555.00 K(-33.7%) |
Sept 2010 | - | $800.00(-99.7%) | $837.30 K(-28.3%) |
June 2010 | - | $268.60 K(-5.6%) | $1.17 M(-14.2%) |
Mar 2010 | - | $284.40 K(+0.3%) | $1.36 M(-11.3%) |
Dec 2009 | $1.53 M(-12.1%) | $283.50 K(-14.3%) | $1.53 M(+22.7%) |
Sept 2009 | - | $330.80 K(-28.3%) | $1.25 M(+36.0%) |
June 2009 | - | $461.60 K(+1.0%) | $918.70 K(+101.0%) |
Mar 2009 | - | $457.10 K(+37.8%) | $457.10 K(+37.8%) |
Dec 2008 | $1.74 M | - | - |
Mar 2008 | - | $331.80 K | $331.80 K |
FAQ
- What is Navidea Biopharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Navidea Biopharmaceuticals?
- What is the all time high quarterly interest expense for Navidea Biopharmaceuticals?
- What is the all time high TTM interest expense for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual interest expense?
The current annual interest expense of NAVB is $1.10 M
What is the all time high annual interest expense for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual interest expense is $1.74 M
What is the all time high quarterly interest expense for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly interest expense is $976.20 K
What is the all time high TTM interest expense for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high TTM interest expense is $2.04 M